The study was aimed to determine the prevalence of Extended Spectrum Beta Lactamase (ESBL) producing Gram negative pathogens from urine samples along with their antimicrobial resistance.
INTRODUCTION
Urinary tract infection (UTI) is a common bacterial infection prevailing in developing countries like Nepal.
UTI is defi ned as a condition in which the urinary tract is infected with a pathogen causing infl ammation. The emergence and occurrence of UTI is increasing day by day. The major Gram-negative bacteria involved in causing UTIs are E. coli, Klebsiella spp, Proteus spp, Pseudomonas spp, Citrobacter spp, Acinetobacter spp with most leading uropathogens E. coli and Klebsiella pneumoniae that belongs to Enterobacteriaceae family (Dromigney et al. 2005) .
Clinical experience has indicated the presence of numerous cases of antibiotic resistance to common antibiotics by uropathogens in both developed and developing countries (Gupta 2002) . The resistivity has posed challenges in choosing empiric regimens. The cause for resistivity against most prescribed broadspectrum beta-lactam antibiotic for treatment against Date of Submission: October 16, 2019 Date of Acceptance: November 15, 2019
Published Online: December, 2019 DOI: https://doi.org/10.3126/tujm.v6i0.26575 TUJM VOL. 6, NO. 1, 2019 Gram negative bacterial infection is the production of extended spectrum beta lactamases. These ESBLs enable these bacilli highly effi cient in inactivating third generation cephalosporins, monobactams and penicillins (Hawkey 2008 ) but cannot inactivate cephamycins or carbapenems and are inhibited by clavulanic acid (Bradford 2001; Bush 2001 and imipenem. MDR isolates were detected based on their resistance to two or more antibiotics (Cheesbrough 2006; CLSI 2014) .
MATERIALS AND METHODS
The isolates exhibiting reduced susceptibility to cefotaxime (30μg) and ceftazidime (30μg) were considered as potential ESBL producers. The ESBL production was phenotypically confi rmed by combination disc method (CLSI 2014). The disc used were cefotaxime and ceftazidime alone and cefotaxime and ceftazidime in combination with clavulanic acid.
A ≥ 5mm increase in growth inhibition zone for any antimicrobial associated with clavulanic acid in comparison with the inhibition zone of antibiotic tested alone confi rmed ESBL production.
The collected data analysis was done by SPSS version 20 software and chi-square test was done as a test of signifi cance. 
RESULTS

Out
DISCUSSION
Increasing number of recent reports on bacterial resistance to beta-lactam antibiotics is of serious concern today as these drugs are used for treatment of most bacterial infections. Failure of empirical therapy is increasing proportionally to increasing rate of ESBL producing pathogens. So, detection of ESBL producing bacteria is highly important and this study was carried out with the same motive.
In this study, out of 300 midstream urine samples processed, 22.7% (n=67) showed the signifi cant growth. 
